📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Sector Averages

About

Selective Insurance Group, Inc., together with its subsidiaries, provides insurance products and services in the United States.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

⭐ Superinvestors Holding SIGI

View All Superinvestors →

Manager	Shares	Value	% of Fund	Period
Jim Simons Renaissance Technologies LLC	112.5K	$8.5M	0.01%	Mar 2026

SEC Form 13F data. 45-day lag from quarter end.

🔍 Concall Decoded

🎙 Management Tone Tracker Confident Specific ~ Volatile 4 quarters analysed

Q2 2025

Confident Specific

Management directly addressed the $45M reserve charge, detailed the specific accident years and sublines affected, and provided concrete actions (e.g., 'renewal pure price increased to 8.9%', 'we continue to execute rate increases above expected loss trend'). They did not hedge or evade, but maintained a confident stance that their current-year assumptions are adequate.

Q3 2025

Cautious

Management acknowledges combined ratio exceeding target and unfavorable prior-year reserve development, but expresses confidence in external reviews and actions to improve fundamentals. The tone is measured, highlighting both challenges and long-term commitment.

Q4 2025

Confident Specific

Management repeatedly expressed confidence in their strategy and provided detailed numbers: 'We are well-positioned to build on recent momentum' and 'Our guidance reflects the benefits we expect in 2026.' They acknowledged challenges but gave specific actions and metrics (e.g., $190M reserve strengthening, 7.5% renewal pure price) to support their outlook.

Q1 2026 latest

Confident Specific

Management highlighted consistent double-digit operating returns and specific pricing actions (e.g., General Liability renewal pure price increases in the 10% range for seven quarters) with no reserve development, showing confidence. They also cautioned about industry-wide social inflation and competitive pressures, but framed their own actions as appropriately responsive.

Guidance Reliability Pending · <3Q data

Investor Lens

The investment thesis is essentially unchanged but reinforced by disciplined execution and stable reserves. Selective continues to prioritize underwriting margins over growth, which may pressure near-term premium volume but positions the company well if industry pricing catches up to loss trends. The absence of reserve development and consistent double-digit ROE support confidence. Key watch items for next quarter: further evolution of retention by cohort, progress on general liability rate increases industry-wide, and any changes to loss cost assumptions given social inflation.

AI-generated concall tone analysis · Updated 2026-06-08 · Not investment advice

🎙 Management Tone Confident Specific ~ Volatile 4 quarters Full tone analysis in Intelligence →

📊 MIXED Selective Insurance Group: 12% Operating ROE, 98.3% Combined Ratio in Q1

Revenue & Profitability

For Q1 2026, diluted EPS was $1.58 and non-GAAP operating EPS was $1.69, producing an 11.2% ROE and a 12% operating ROE. The GAAP combined ratio was 98.3, including 6.2 points of catastrophe losses. The underlying combined ratio was 92.1. After-tax net investment income was $113 million, up 18% year-over-year. There was no prior year casualty reserve development.

Outlook

Management notes that social inflation continues to pressure recent accident years, particularly in General Liability, Commercial Auto liability, and umbrella. While industry pricing in Commercial Auto has been firmer, General Liability pricing has not fully adjusted upward. Selective expects its own actions to position it well. The company reaffirmed 2026 guidance: GAAP combined ratio of 96.5%-97.5% (assuming six points of catastrophe losses) and after-tax net investment income of $465 million.

Growth Drivers

Growth is driven by targeted expansion in Standard Commercial Lines through existing agency partners and new agency locations within its geographic footprint. In Personal Lines, the mass affluent target business grew 1%. E&S grew 1% in Q1. The company is intentionally shifting portfolio mix away from contractors to improve margin durability. Strategic investments in AI aim to improve risk selection and productivity.

Balance Sheet & CapEx

Selective continues to invest in technology, with a significant portion of 2026 strategic tech investments focused on improving risk selection, pricing accuracy, and productivity. Specific AI tools highlighted include a claims ingestion tool (500,000 documents processed) and automation for contractual risk transfer evaluation (over 90% results in two minutes). AI governance is maintained through a cross-disciplinary committee with human-in-the-loop oversight.

Margins

The Q1 underlying combined ratio of 92.1 is higher than the full-year target due to normal seasonality; full-year underlying combined ratio is expected to be within the original 90.5%-91.5% range. Management expects improved underwriting margins from mix improvement actions and continued earning of strong renewal pricing. The GAAP combined ratio guidance for 2026 is 96.5%-97.5%. Expense ratio management is a focus as top line tempers.

Key Risks

Key risks flagged by management include social inflation causing elevated severity trends in General Liability, Commercial Auto liability, and umbrella. The industry faces continued adverse reserve development, though Selective reported none this quarter. Competitive pressure and pricing that may not fully adjust to loss trends pose risks. New Jersey auto trends remain elevated. Selective's own underwriting actions, while deliberate, could further pressure top-line growth.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 2026-07-24

Delivered strong investment income and double-digit operating ROE, with all segments profitable despite premium declines and elevated commercial auto frequency. Guidance for the year remains at the high end of the combined ratio range, with increased investment income expectations.

Q1 2026 Q1 2026 2026-04-23

Solid Q1 2026 results with 12% operating ROE, improved underwriting margins, and strong investment income. Disciplined pricing and portfolio diversification offset competitive pressures, while guidance for 2026 is reaffirmed.

Q4 2025 Q4 2025 2026-01-30

Delivered strong 2025 results with 14.4% ROE, 18% book value growth, and improved combined ratios. 2026 guidance anticipates further margin gains, increased investment income, and continued technology investment, while maintaining disciplined underwriting and capital management.

Q3 2025 Q3 2025 2025-10-23

Operating ROE reached 13.2% with strong investment income, but the combined ratio rose to 98.6% due to reserve strengthening in commercial auto, especially in New Jersey. Premium growth slowed, but capital returns increased with a 13% dividend hike and new $200M buyback authorization.

Q2 2025 Q2 2025 2025-07-24

Operating ROE reached 10.3% with strong investment income and segment growth, but unfavorable prior year casualty reserve development led to a 100.2% combined ratio and raised full-year guidance. Social inflation and paid claim emergence continue to drive uncertainty, while capital and investment positions remain strong.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.